Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic Malignancies

Gynecologic cancers cause over 600,000 deaths annually in women worldwide. The development of chemoresistance after initial rounds of chemotherapy contributes to tumor relapse and death due to gynecologic malignancies. In this regard, cancer stem cells (CSCs), a subpopulation of stem cells with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Muralikrishnan, Vaishnavi, Hurley, Thomas D., Nephew, Kenneth P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225959/
https://www.ncbi.nlm.nih.gov/pubmed/32295073
http://dx.doi.org/10.3390/cancers12040961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225959/
https://www.ncbi.nlm.nih.gov/pubmed/32295073
http://dx.doi.org/10.3390/cancers12040961

Ejemplares similares